-
Abstract Number: 2551
Modified Delphi Process to Propose an Equity Measurement Roadmap in Rheumatology
-
Abstract Number: 2552
Changes in Social Determinants of Health Needs Uncovered by a Rheumatology-Based Screening and Assistance Program
-
Abstract Number: 2553
Predictors of Biologic and Targeted Synthetic DMARD Initiation for Rheumatoid Arthritis Across Underserved Patient Groups: Insights from a National Cohort Study
-
Abstract Number: 2554
Prevalence and Clinical Characteristics of Vasculitis in the Alaska Native and American Indian Peoples of Alaska
-
Abstract Number: 2555
Addressing Economic Insecurities Could Improve Patient-Reported Outcomes in Lupus
-
Abstract Number: 2556
A Multi-center Study of Associations Between Neighborhood-Level Child Opportunity, Initial Disease Severity and Acute Care Utilization Among Children with SLE
-
Abstract Number: 2557
The Relation of Colchicine to Knee/hip Replacement Among People with Gout in a Population-based Cohort Study
-
Abstract Number: 2558
Development of Non-genetic Risk Stratification Model of Severe Allopurinol Hypersensitivity Syndrome, a Multicenter Study in Thailand
-
Abstract Number: 2559
Relationship Between Serum Urate and Changes in Dual Energy Computed Tomography MSU Crystal Volume over One Year in People with Gout: An Individual Participant Data Analysis
-
Abstract Number: 2560
Continuous Reduction in Ultrasound Detected Crystal Depositions over 5 Years Follow-up: Results from the NOR-Gout Study
-
Abstract Number: 2561
Circulating Proteomic Profiles and Incident Gout Risk: Prospective Cohort Study of >48,000 Men and Women
-
Abstract Number: 2562
Efficacy and Safety of Tocilizumab in the Treatment of Chronic Inflammatory Forms of CPPD: Retrospective Study of 55 Cases
-
Abstract Number: 2563
Efficacy and Safety Results of CT-P41 (Proposed Denosumab Biosimilar) Compared to Reference Denosumab in Postmenopausal Women with Osteoporosis: 78-Week Results from Phase 3 Randomized Controlled Trial
-
Abstract Number: 2564
Providing Optimal and Equitable Osteoporosis Treatment Using a Programmatic Approach -A 20 Year Longitudinal Study
-
Abstract Number: 2565
A Randomized, Double-blind, Multicenter, Parallel-arm Phase 3 Study to Compare the Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab-1000 and Prolia in Postmenopausal Women with Osteoporosis
- « Previous Page
- 1
- …
- 170
- 171
- 172
- 173
- 174
- …
- 181
- Next Page »